Healthcare >> CEO Interviews >> October 23, 2015

Interview with the CEO, President and Director: Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)

Kidron, Nadav
Nadav Kidron, Esq., serves as Chief Executive Officer, President and Director of Oramed Pharmaceuticals Inc., which he co-founded in 2006. Mr. Kidron is an entrepreneur whose experience includes senior executive roles in a wide range of industries. He is a member on the board of directors of Entera Bio, which started as a joint venture formed by Oramed and DNA Biomedical Solutions, and an international lecturer on Israel’s entrepreneurial culture and the country’s roots as an oasis of innovative ideas. He holds a bachelor’s degree in law and an international master’s in business administration, both from Bar-Ilan University in Israel. Mr. Kidron is a fellow of the Merage Business Executive Leadership Program and a member of the Israeli Bar Association. Profile
TWST: Could you provide a brief overview of the company?

Mr. Kidron: Oramed Pharmaceuticals has a platform technology that allows us to take therapeutic proteins and deliver them